Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Modulation of substrate utilization can improve myocardial function during ex situ heart perfusion
FY 2020-21
Summary
Heart failure (HF) is one of the most rapidly rising diseases in Canada with 1.4 million people hospitalized annually with this diagnosis. For patients with end-stage HF, transplantation remains the gold standard. Unfortunately, there has been a widening gap between the number of donors and recipients, which led to death on the waiting list. Currently, we cannot procure more hearts for transplant due to our basic organ storage solution, where a heart is simply stored on ice. Without the ability to evaluate and preserve hearts during transport, we are limited to donors who have suffered brain death, where we can evaluate the heart's function before procurement. This precludes us from donors who have suffered circulatory arrest because we cannot assess their heart before procurement. Ex situ heart perfusion (ESHP) has been developed to reanimate hearts outside of the body on a machine where it can be assessed for function. This technology will allow us to procure hearts from circulatory arrest donors and increase donation rates by 30%. However, these reanimated hearts deteriorate after the first hour. It is known that the dysregulation in the heart's metabolism is causing this decline. However, there is a knowledge gap on how this dysregulation occurs. We will close this gap by studying the entire metabolome of the heart during ESHP. Using microextraction fibers, we will analyze the heart's metabolome using a machine learning algorithm that will output the most disturbed metabolites. We will then design a cocktail using this information to prevent the heart's decline. Preventing decline during ESHP can be impactful by allowing hearts to endure longer transport times; thus, providing more options and more hearts for the long list of patients waiting for a transplant.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449829
Name
Yu Changyuan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Modulation of substrate utilization can improve myocardial function during ex situ heart perfusion
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiac Surgery; Cardiology; Ex Situ Heart Perfusion; Heart Failure; Lipidomics; Metabolome; Metabolomics
Abstract
Heart failure (HF) is one of the most rapidly rising diseases in Canada with 1.4 million people hospitalized annually with this diagnosis. For patients with end-stage HF, transplantation remains the gold standard. Unfortunately, there has been a widening gap between the number of donors and recipients, which led to death on the waiting list. Currently, we cannot procure more hearts for transplant due to our basic organ storage solution, where a heart is simply stored on ice. Without the ability to evaluate and preserve hearts during transport, we are limited to donors who have suffered brain death, where we can evaluate the heart's function before procurement. This precludes us from donors who have suffered circulatory arrest because we cannot assess their heart before procurement. Ex situ heart perfusion (ESHP) has been developed to reanimate hearts outside of the body on a machine where it can be assessed for function. This technology will allow us to procure hearts from circulatory arrest donors and increase donation rates by 30%. However, these reanimated hearts deteriorate after the first hour. It is known that the dysregulation in the heart's metabolism is causing this decline. However, there is a knowledge gap on how this dysregulation occurs. We will close this gap by studying the entire metabolome of the heart during ESHP. Using microextraction fibers, we will analyze the heart's metabolome using a machine learning algorithm that will output the most disturbed metabolites. We will then design a cocktail using this information to prevent the heart's decline. Preventing decline during ESHP can be impactful by allowing hearts to endure longer transport times; thus, providing more options and more hearts for the long list of patients waiting for a transplant.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yu, Changyuan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~